glp-1 receptor agonists benefits for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes GLP-1 Agonists: Using Semaglutide, Tirzepatide,

A., Wishart, J., Horowitz, M., & Feinle-Bisset, C

10.3892/or.2015.4476 [DOI] [PubMed] [Google Scholar] 218.He W, Yu S, Wang L, He M, Cao X, Li Y, et al

According to a 2024 poll, the number of people in the United States who started using GLP-1 agonists for weight loss has increased by 700-fold in just four years from 2019 to 2023

Both drugs carry warnings in patients with a history of medullary thyroid carcinoma or MEN2 syndrome

GLP-1 RAs face a mix of regulatory hurdles across Latin America, shaped by fragmented healthcare systems, evolving drug policies, and rising demand

Investigations conducted at 2023 have shown that vitamin D may also increase GLP-1 levels through the improvement of a healthy gut microbiome